RayzeBio, Inc. Common Stock
RayzeBio, Inc. Common Stock (RYZB) Stock Overview
Explore RayzeBio, Inc. Common Stock’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
3.8B
P/E Ratio
-35.73
EPS (TTM)
$-1.08
ROE
0.83%
RYZB Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of RayzeBio, Inc. Common Stock (RYZB) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
Our forecasting models predict significant price movements, with a 12-month target of $205.36.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -35.73 and a market capitalization of 3.8B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.